Correction to: Lifespan effects in male UM-HET3 mice treated with sodium thiosulfate, 16-hydroxyestriol, and late-start canagliflozin (GeroScience, (2024), 46, 5, (4657-4670), 10.1007/s11357-024-01176-2)

Unfortunately, the original version of this article contained errors. There are five places in the paper where a drug is mistakenly referred to as “16-hydroxyestriol.” The correct name of this drug is “16-hydroxyestradiol.” The five affected instances are shown below. In the Article Title, the sentence should be corrected FROM: Lifespan effects in male UM‑HET3 mice treated with sodium thiosulfate, 16‑hydroxyestriol, and late‑start canagliflozin. TO: Lifespan effects in male UM-HET3 mice treated with sodium thiosulfate, 16-hydroxyestradiol, and late-start canagliflozin. In the Abstract section, the sentence should be corrected FROM: Genetically heterogeneous UM-HET3 mice born in 2020 were used to test possible lifespan effects of alpha-ketoglutarate (AKG), 2,4-dinitrophe- nol (DNP), hydralazine (HYD), nebivolol (NEBI), 16α-hydroxyestriol (OH_Est), and sodium thiosulfate (THIO), and to evaluate the effects of canagliflozin (Cana) when started at 16 months of age. TO: Genetically heterogeneous UM-HET3 mice born in 2020 were used to test possible lifespan effects of alpha-ketoglutarate (AKG), 2,4-dinitrophe- nol (DNP), hydralazine (HYD), nebivolol (NEBI), 16-hydroxyestradiol (OH_Est), and sodium thiosulfate (THIO), and to evaluate the effects of canagliflozin (Cana) when started at 16 months of age. In the Introduction section, the sentence should be corrected FROM: One of the newly tested agents, 16-hydroxyestriol (OH_Est), was found to produce significant lifespan extension in male, but not female, mice, with a 15% increase in median lifespan. TO: One of the newly tested agents, 16-hydroxyestradiol (OH_Est), was found to produce significant lifespan extension in male, but not female, mice, with a 15% increase in median lifespan. In the Discussion section, the sentence should be corrected FROM: This report adds another agent to the list of those shown by the ITP to increase mouse lifespan to a significant degree, i.e., 16-hydroxyestriol. TO: This report adds another agent to the list of those shown by the ITP to increase mouse lifespan to a significant degree, i.e., 16-hydroxyestradiol.